Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS2893392 A
Publication typeGrant
Publication dateJul 7, 1959
Filing dateJan 8, 1958
Priority dateJan 8, 1958
Publication numberUS 2893392 A, US 2893392A, US-A-2893392, US2893392 A, US2893392A
InventorsRichard Wagner Alan, Sam Cooper Murray
Original AssigneeAmerican Cyanamid Co
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Article of manufacture for intracutaneous injections
US 2893392 A
Previous page
Next page
Description  (OCR text may contain errors)

y 1959 A. R: WAGNER ETAL 2,893,392-


8 INVENTOR. ALAN RICHARD WAGNER BY MURRAY SAM COCPER ATTORNEY United States Patent ARTlCLEDFMANUFACTURE FORINTRA- 'CUTANEOUS INJECTIONS Richard -Wagner, Park *Ridge, and Murray Sam -.-.Cooper, Dumont N.J. assiguors; to American Cyan- .ainid Company, New York, N.Y., a corporation of 7 Metric -Application January 8, :-1958, SeriaI No. 707,703 51Cl2'1inis. (Cl; 128-153) This "invention relates'to an article ofmanufacture "-suit'able 'for useas a means -of:administering' intracutaneousinje'ctions, a more particularly; to 21* unit consisting of a sealed container which encloses both a'biolog'ically "active *fluid' and a device capable of puncturing this container and administering a single-puncture or a multiple- *pim'eture intracutaneous injection. In a preferred em- -lfxidirrient, it consists of'a disposable sealed plastic conner'--which"encloses both a biologically active'fiuid c pable-ofeli'citing an-allergic reaction or producing a vaceinirermuocai infection and a plate or 'disk, which *dislc-"or"plate is perforated in such manner that one or a nmiiber-"of sharp-pointsare formed which-are capable be-puncturin the plastic container and also penetrating iilt: the skin" beneath the plastic container thereby adnist in'g asingle-puncture or multiple-puncture intracutaneous injection.

intracutaneousinjections are employed inmedical prac- -ti ef6ra wide= variety ofpurposes. They are used-to vaci mate againsta number of diseases such' as smallpox and "ti lbetculosis. They are used-diagnostically to'dete'ct allergies of various kinds and sensitivity toa wide-variety of biological products such as penicillin, horse -serum,-and "variousroorganisms {such as those causing tuberculosis'. I racutaneousinjections are also used'asmeans or: desensitizing aninialsagainst-a wide-variety ofallergens. Various techniqueshave been developed for the application or these vaccinating and diagnostic agents and allergens,-but each of *these has certain disadvantages.

-Direct skin su'rface contact tests are 'painless and re- -=quire little skillin applicationfbut are unreliable and "u -some areas of "the world extremely difiicult to use. or e'xample, adhesivepla's'ter frequently does not hold -to:pe1 'spiringskin-areas and -may irritate the skin, thus eliciting false pos'it-ive reactions, as some skin surface areas are more "s'ensitive than others. Thus, test results -may'be erratic.

Abrasion or scratch tests are relatively painless, but =-'they necessitate expert tech'nique andhave proved unreliable in many instanc'es and places. For example, it is difiicult to 'applyan abrasive contained in grease to a per'spirin'g skin, "scratches may vary in depth, glass containers' of test fluid may become contaminated, and the like.

-Intracutaneousinjection methods are used throughout *rthe-worldwhere accurate and reproducible information -is desired. Most of these testsare' performed at present bysinjection directlydnto the skin by means of singleor multiple-dose syringes, carpules, "syrettes-and the like, or alternatively, by some adaptation of a device which admini's'tei's -multiple skin punctures by means of a vertical stabbing through a'drop of test material placed on the surface; of the skin. Difliculties have been encounf'tered'inperfofming ihtr'acutaneous injections by present l techniques. L Singleand inultiple dose syringes-are'relativ'ely' expensive;have a tendency to leak, and are easily broken. Separate syringes and needles are preferred for each test to avoid transmittal of bloodborne diseases and contamination.

-2 (homologous 'serum hepa'titis, etc.) L fronr one person to another. False tests have resulted from contamination by traces of allergen that remain in the syringes-even after thorough washing and boiling-especially in cases where a'weaker allergen has been used subsequent to a strong allergen; Contamination of bottles of testmaterial-may culties are frequently encountered. 'Carpules' are also relatively expensive and'the 'glass cartridgesare-subje'ct to breakage. Separate needles-"should'beusedto -avoid 'transmi'ttal of bloodborne diseases fromone'personto "another.

Syrettes are' dispos able"and dosolve thefproblem er "expense, breakagepa'n'd contamination. Howevenanother problem common -to-syringes, carpules, aud s grade assistantsextremely difiicult.

*Some multiple-puncture devices are relatively expensive, not easily obtainable, and have energized moving parts which are subject to break-down-and which have a noise-plus-shock type of action that 'may render-children and nativepopulations uncooperative.

Other multiple puncture devices, such-as pronged steel disks,--with or without holders, usuallynecessitate the use of glass vials or glass capillary tubes as containers" for test materials and therefore'introduce the dangers of breakage Distancefrom a source "of supply might result in the presence of disks Without test material or testmaterial without disks.

"An object of this invention is -to:provide a single-puncture or multiple-puncture type,--'self-contained skin-test "unit which-is disposable, inexpensive, unbreakable, sterilizable, capable ofbeing'standardized and capableof practically painless, easy, fool-proof operation in the hands of-unskilled personnel. The last mentionedis an especially important featureof the-invention; that is, it is simply and easily put to use by p'ersonswithout specialized training. Another important'feature of the invention lies in thefact that it canbe produced in 'a wide range of sizes.

Another important feature ofthe invention is the fact that, as long as the test material is'fluidand does not deteriorate too quickly, any desired: single dose of any test material may be-inc'orporated'in the unit.

In order that the nature of 'the'invention may be more apparent, reference is made to the single sheet of drawunit of Figure 3 taken along line 5,-5.

Figure 6 is a perspective view of the unit ofFigure 3. Figure 7 is a perspective view of a somewhat modi- "fied injection device.

Figure 8 is also a perspective view of another form of injection device.

Figure '9 is a plan view of"stillanother'modification of the injection device.

Figure 10 is across-sectional view taken'along line It), f Figure 9.

Referring again to Figure 1, the injection device of the present invention comprises a plastic envelope 1 containing an injection unit 2 with sharp prongs 3, 4, 5

3 and 6, enclosed within the plastic envelope together with a quantity of a biological liquid 7. The ends and 9 of the plastic envelope are 'sealed, forming a liquid-tight container holding the biological liquid and the injection device.

The biological liquid may be any suitable biological material which is to be used in the intracutaneous injection. When running tests, for instance, to determine whether or not the subject has tuberculosis, the biological liquid would be old tuberculin often referred to as OT whichmay be prepared by evaporating a twelveweek old culture of tubercle bacilli in percent glycerine bouillon down to one-tenth of its original volume, heating to kill the bacteria and filtering to obtain old tuberculin, an amber syrupy fluid which will keep for a longer period of time. A suitable amount of this particular biological liquid to include in each envelope would be about one-half milliliter although smaller or larger volumes may be used. Obviously, different amounts of other biological liquids would be employed as determined by the manufacturer of the unit.

The plastic envelope should be biologically inert, water insoluble and impermeable and, preferably, should be resistant to other organic liquids such as glycerol wthich isoften used in the preparation of vaccines and diagnostic agents. It should be resistant to alcohols. The assembled units as described herein may be stored in ethyl alcohol as a means of keeping the unit aseptic just as surgical sutures are often stored in tubing fluids.

Preferably the envelopeshould be transparent so that those who are using the device may quickly determine where the injection prongs are located, although obviously location of the prongs can be designated in any suitable manner.

Inasmuch as it may be desired to heat-sterilize the unit after assembling and sealing, the plastic envelope should be of a heat-resistant material that is suflicient to withstand sterilizing temperatures. However, when other means of sterilization are employed, heat resistance is not particularly important.

The plastic envelope should also be fairly flexible for ease in handling and applying. The material should be strong enough to withstand packaging operations and handling, yet should be readily pierceable by the injection prongs on the unit within the plastic envelope. Fortunately there are several suitable plastic films available from which the plastic envelope may be made. These includepolyethylene films, films made of polymers of ethylene glycol and terephthalic acid, films of polyvinylidene chloride, vinyl resins, rubber hydrochloride and others sold under such trade'names as Saran, Mylar, Genitron, Pliofilm, and Cryovac. Suitable films range from about 0.0005 inch and thicker, the practical limit being dependent upon the difficulty with which the film may be punctured by the sharp prongs of the injection unit without undue pressure.

The injection unit itself may take a variety of forms some of which are illustrated in Figures 6, 7, 8, and 9. It should be of a non-corrosive material such as stainless steel. There may be only one injection prong as shown in Figure 8 or there may be a multiplicity of prongs. Preferably, but not necessarily, the device should be substantially flat so that pressure may be readily inserted upon it by the thumb or finger. The prongs are preferably about 2 to 3 millimeters in length although they may range from 1 to 5 millimeters depending upon the use to which the instrument is put. A suitable size of the unit as shown in Figure 3 is approximately Y by 7 inch, although obviously larger or smaller units may be used.

The envelope containing the biological liquid of the injection unit may be sealed by any means suitable to the plastic material of which the envelope is made. Heat-sealing is preferred although other means may be employed.

In employing this self-contained, disposable transparent, multiple-puncture, intracutaneous injection pacquet, the terminal quarters of the unit are grasped between the thumb and index finger of each hand and placed against the skin test area in such a way that the sharp points are vertical to the skin surface. The unit is then held in place with one hand and pressure applied by means of the thumb of the other hand is used to drive the points through the wall of the plastic film container and into the skin carrying the test fluid along. Pressure on the plasticfilm tends, of course, to force the liquid within the envelope out and into contact with the skin through which it is carried by the points of the instrument.

This invention may be usefully employed in individual or mass investigations for tuberculin and tetanus sensitivity, diagnosis of histoplasmosis, blastomycosis, coccidimycosis, cryptococcosis, sporotrichosis, allergen sensitivity, smallpox vaccination, and many other purposes wherein intracutaneous injection of a biological is de sired.

Various ways of assembling the article of the present invention will occur to those skilled in the packaging art. A method of assembly suitable to automation is to cut and simultaneously seal short sections from a preformed tube of plastic material, insert the injection disk in the unsealed end, add a desired quantity of the biological liquid, heat-seal the open end of the tube and sterilize the entire unit by heating in a steam autoclave at 5 to 10 pounds pressure for 30 minutes. If the biological liquid is heat-labile, it may be introduced aseptically into the unit after sterilization. Of course, sterilization with ethylene oxide, radiant energy, antiseptics and other means may be employed instead of heat Where practical. Inasmuch as the treatment of these biological liquids will be understood by those skilled in the art, further elaboration appears to be unnecessary.

We claim:

1. An article of manufacture comprising a sealed envelope containing a quantity of biological liquid and an injection device adapted to penetrate the envelope and the epidermis of an animal.

2. An article of manufacture adapted for use in administering intracutaneous injections of a biologically active material comprising a sealed container of pliable film containing a biologically active liquid and an injection device comprising a substantially fiat body having at least one injection prong adapted to penetrate the pliable film and the epidermis of a subject when the unit is placed on the skin and pressure is applied.

3. An article of manufacture in accordance with claim 2 in which the injection prongs are from 1 to 5 millimeters in length.

4. An article of manufacture in accordance with claim 2 in which the injection unit comprises a substantially flat disk of a non-corrosive metal having a plurality of injection prongs of from 1 to 5 millimeters in length.

5. An article of manufacture for intracutaneous injection of old tuberculin which comprises a sealed transparent plastic envelope containing old tuberculin and a substantially flat body having a plurality of sharp prongs of l to 5 millimeters in length adapted to penetrate the envelope and penetrate the skin of a test subject upon application of pressure.

References Cited in the file of this patent UNITED STATES PATENTS 2,619,962 Rosenthal Dec. 2, 1952 2,817,336 Kravitz Dec. 24, l957 2,841,138 Laub July 1, 1958

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2619962 *Feb 19, 1948Dec 2, 1952Res FoundationVaccination appliance
US2817336 *Dec 20, 1952Dec 24, 1957Harvey KravitzMeans for vaccinating
US2841138 *Mar 11, 1957Jul 1, 1958Laub Ernest S VAllergy testing device
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3034507 *May 10, 1960May 15, 1962American Cyanamid CoIntracutaneous injection device
US3072122 *Jan 15, 1959Jan 8, 1963Roy Rosenthal SolPackage for transcutaneous injection
US3074403 *May 17, 1960Jan 22, 1963American Cyanamid CoIntracutaneous injector with capillary gap
US3136314 *Aug 1, 1960Jun 9, 1964Harvey KravitzVaccinating devices
US3167073 *Jan 16, 1962Jan 26, 1965Roy Rosenthal SolTranscutaneous injection device
US3221739 *Mar 26, 1962Dec 7, 1965Roy Rosenthal SolInjection device
US3221740 *Aug 31, 1962Dec 7, 1965Roy Rosenthal SolInjection device
US3246647 *Jul 23, 1962Apr 19, 1966American Cyanamid CoDisposable intracutaneous injector
US3291129 *Aug 8, 1963Dec 13, 1966Paul Merieux Charles FrancisquScarificator for use in vaccination, skin tests, or the like
US3703890 *Aug 10, 1970Nov 28, 1972Saunders Milton A JrSkin patch test device
US3882999 *Oct 29, 1973May 13, 1975Wellman Lester ROpener/re-closer for sealed containers
US4802493 *Feb 17, 1987Feb 7, 1989Maganias Nicholas HDevice and method for allergy testing
US5099857 *May 27, 1988Mar 31, 1992Northern Sydney Area Health ServiceMedical testing device with calibrated indicia
US5104620 *Jul 30, 1990Apr 14, 1992Wiley Fred RDisposable allergy skin testing kit
US6083196 *Dec 9, 1998Jul 4, 2000Alza CorporationDevice for enhancing transdermal agent flux
US6219574Jun 17, 1997Apr 17, 2001Alza CorporationDevice and method for enchancing transdermal sampling
US6322808Dec 9, 1998Nov 27, 2001Alza CorporationDevice for enhancing transdermal agent flux
US6334856May 21, 1999Jan 1, 2002Georgia Tech Research CorporationMicroneedle devices and methods of manufacture and use thereof
US6443307 *Jan 25, 2000Sep 3, 2002Michael D. BurridgeMedication dispenser with an internal ejector
US6503231Jun 10, 1998Jan 7, 2003Georgia Tech Research CorporationMicroneedle device for transport of molecules across tissue
US6611707Dec 2, 1999Aug 26, 2003Georgia Tech Research CorporationMicroneedle drug delivery device
US6743211Nov 23, 1999Jun 1, 2004Georgia Tech Research CorporationDevices and methods for enhanced microneedle penetration of biological barriers
US6953589Oct 4, 2000Oct 11, 2005Alza CorporationDrug delivery device comprising sheets having microstructure projections and rigid supports for applying force and penetrating the skin; medical equipment
US7027478Dec 20, 2001Apr 11, 2006Biovalve Technologies, Inc.Microneedle array systems
US7184826Jun 17, 1997Feb 27, 2007Alza CorporationDevice and method for enhancing transdermal flux of agents being delivered or sampled
US7226439Jun 4, 2003Jun 5, 2007Georgia Tech Research CorporationMicroneedle drug delivery device
US7344499Dec 2, 1999Mar 18, 2008Georgia Tech Research CorporationMicroneedle device for extraction and sensing of bodily fluids
US7537795Oct 26, 2001May 26, 2009Alza CorporationAgent is dissolved in water to form aqueous coating solution for coating extremely tiny skin piercing elements, solution is applied to skin piercing elements, dried, device is applied to skin of a living animal causing microprotrusions to pierce stratum corneum and deliver drug
US7556821Mar 18, 2005Jul 7, 2009Alza CorporationDelivery system having a microprojection member that includes a plurality of microprojections adapted to pierce through stratum corneum into underlying epidermis layer; improved pharmacokinetics can comprise increased bioavailability of the PTH-based agent; treatment of osteoporosis and bone fractures
US7579013Jun 29, 2004Aug 25, 2009Alza CorporationTransdermal drug delivery device having stratum corneum-piercing microprojections; pH stability and solubility when dried;
US7658728Jan 10, 2006Feb 9, 2010Yuzhakov Vadim VMicroneedle array, patch, and applicator for transdermal drug delivery
US7785301Nov 28, 2006Aug 31, 2010Vadim V YuzhakovTissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection
US7861712Apr 23, 2004Jan 4, 2011Manta Product DevelopmentSealed capsule including an integrated puncturing mechanism
US8116860Jan 22, 2008Feb 14, 2012Altea Therapeutics CorporationTransdermal porator and patch system and method for using same
US8257324May 21, 2007Sep 4, 2012Georgia Tech Research CorporationMicroneedle drug delivery device
US8342176Dec 20, 2010Jan 1, 2013Manta Devices, LlcSealed capsule including an integrated puncturing mechanism
US8361022Jul 1, 2009Jan 29, 2013Alza CorporationApparatus for transdermal delivery of parathyroid hormone agents
US8361037Sep 19, 2002Jan 29, 2013Valeritas, Inc.Microneedles, microneedle arrays, and systems and methods relating to same
US8414548Jan 27, 2010Apr 9, 2013Vadim V. YuzhakovMethod of making microneedle array and device for applying microneedle array to skin
US8430805May 20, 2009Apr 30, 2013Emkinetics, Inc.Method and apparatus for magnetic induction therapy
US8435166May 20, 2009May 7, 2013Emkinetics, Inc.Method and apparatus for magnetic induction therapy
US8550074Jan 15, 2010Oct 8, 2013Manta Devices, LlcDelivery device and related methods
US8588884May 28, 2010Nov 19, 2013Emkinetics, Inc.Microneedle electrode
US8607787Oct 9, 2012Dec 17, 2013Manta Devices, LlcDose delivery device for inhalation
US8627818Dec 28, 2012Jan 14, 2014Manta Devices, LlcSealed capsule including an integrated puncturing mechanism
US8632801Dec 28, 2006Jan 21, 2014Alza CorporationStable therapeutic formulations
US8706210Jan 27, 2009Apr 22, 2014Nitto Denko CorporationTransdermal integrated actuator device, methods of making and using same
US8708966Aug 9, 2010Apr 29, 2014Georgia Tech Research CorporationMicroneedle devices and methods of manufacture and use thereof
US8763605Jul 20, 2006Jul 1, 2014Manta Devices, LlcInhalation device
EP0081975A2 *Dec 8, 1982Jun 22, 1983Nicholas H. MaganiasDevice and method for allergy testing
U.S. Classification604/47, 206/229, 600/556, 206/367, 206/222
International ClassificationA61B17/20
Cooperative ClassificationA61B17/205
European ClassificationA61B17/20B